TOday’s Movers: AmSurg (NASDAQ:AMSG) Stock Rating Has Been Reiterated at Stephens; $97.00 Target Price Indicates 18.28% Potential


AmSurg (NASDAQ:AMSG) Rating Reaffirmed

The brokerage firm has just set a PT of $97.00 on AmSurg (NASDAQ:AMSG) shares. This is 18.28% from the last stock close. In a comprehensive report issued to investors and clients on 14 December, Stephens kept steady their “Overweight” rating on shares of AMSG.

From a total of 12 analysts covering AmSurg (NASDAQ:AMSG) stock, 11 rate it a ”Buy”, 1 a “Sell”, and 0 a ”Hold”. This means that 92% of the ratings are positive. The highest target price is $101 while the lowest target price is $70. The mean of all analyst targets is $92 with a 14.28% above today’s ($81.38) stock price. AmSurg was the topic of 5 analyst reports since August 6, 2015 according to the firm StockzIntelligence Inc. Goldman Sachs reinitiated shares on November 30 with “Buy” rating.

Approximately 279,991 shares of stock traded hands. Amsurg Corp (NASDAQ:AMSG) has risen 24.29% since May 11, 2015 and is uptrending. It has outperformed by 28.70% the S&P500.

The overall sentiment of institutions has decreased to 1.09 in Q2 2015. Its down 0.28, from 1.37 in 2015Q2. The ratio is negative, as 34 institutions have sold all the shares of Amsurg Corp that they owned while 100 funds have taken shares off the table. 46 funds have purchased shares for the first time while 100 added to their positions. These institutions now hold 56.88 million shares or 20.15% more than the 47.34 million shares they owned in 2015Q2.

The Fund Scholtz & Company Llc currently is holding shares equating to 4.89% of its total portfolio in Amsurg Corp representing a total of 58,870 shares. Another fund,Three Peaks Capital Management Llc, is holding a total of 210,799 shares equating to 4.03% of their holdings. Additionally, Insight Capital Research & Management Inc has a 133,974 share stake in Amsurg Corp which represents 3.15% of their total portfolio. The Fund, Hood River Capital Management Llc, based out of Oregon, has also built up a stake in the stock, which represents a total of 3.07% of their total portfolio. Finally Aristotle Capital Boston Llc, a fund which is based in the state of Massachusetts reported a total holdings of 142,900 shares.

Insider activity is a very important aspect to track on any stock. Going back to March 23, 2015, shareholders of Amsurg Corp have witnessed 0 insider buys, and a total of 4 sales equating to a net activity of approximately $4.21 million . Holden Christopher A sold 3,000 shares worth approximately $231,012. Gulmi Claire M sold 15,000 shares worth approximately $1.27 million. Coward Robert Jon sold 30,000 shares worth approximately $2.50 million. Lavender Kevin P sold 2,500 shares worth approximately $154,992. The company insider Clendenin Phillip A sold 9,598 shares worth $603,550.

AmSurg Corp. is the owner and operator of ambulatory surgery centers in the United States. The company has a market cap of $4.37 billion. The Firm is also a well-known provider of outsourced physician services in the areas of anesthesiology, children’s services, emergency medicine and radiology. It has 34.49 P/E ratio. The Firm operates in two divisions: ambulatory surgery services and outsourced physician services.

According to Zacks Investment Research, “AmSurg Corp. is in the business of developing, acquiring and operating practice-based ambulatory surgery centers, in partnerships with physician practice groups, throughout the United States. An AmSurg surgery center is typically located adjacent to or in the immediate vicinity of the specialty medical practice of a physician group partner’s office. Each of the surgery centers provides a narrow range of high volume, lower-risk surgical procedures, generally in a single specialty.”